PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Aug-2022 Eureka Therapeutics Announces Publication of Crystal Structure of TCR Mimic Redirected T Cells Targeting Alpha-Fetoprotein (AFP) for Liver Cancer Businesswire
03-Aug-2022 Shape Memory Medical Celebrates Treatment of 1,500th Patient Businesswire
03-Aug-2022 Assure Infusions to Build Pharmaceutical Manufacturing Facility in Central Florida Businesswire
03-Aug-2022 Amneal Appoints Deborah M. Autor to Board of Directors Businesswire
03-Aug-2022 Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis Businesswire
03-Aug-2022 OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration Businesswire
03-Aug-2022 PharmaEssentia Appoints Dr. Lih-Ling Lin as Chief Scientific Officer Businesswire
03-Aug-2022 Biological Dynamics to Present at the 2022 UBS Genomics 2.0 and MedTech Innovations Summit Businesswire
03-Aug-2022 Soleo Health One of a Select Few Specialty Pharmacies Chosen to Provide Cuvitru® to Patients Businesswire
03-Aug-2022 Asia Pacific Self-Adhesive Labels Market Report 2022: Increased Urbanisation, Need for Pharmaceutical Product Supply, Rising Consumer Awareness & the Rise of the E-Commerce Industry Driving Growth - ResearchAndMarkets.com Businesswire
03-Aug-2022 Global Adhesives & Sealants Market Insights & Forecasts 2022-2026 with Potential Impact of COVID-19 - ResearchAndMarkets.com Businesswire
03-Aug-2022 Global Healthcare BPO Market Trajectory & Analytics Report 2022: Inherent Advantages of Cloud Computing Make "The Cloud" a Game Changer in the Healthcare BPO Industry - ResearchAndMarkets.com Businesswire
03-Aug-2022 Absolute Antibody Increases Automation Capabilities and Expands Production Facility to Support Continued Growth of its Recombinant Antibody Technology Absolute Antibody
03-Aug-2022 AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients Businesswire
03-Aug-2022 Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance Businesswire
03-Aug-2022 Charles River Laboratories Announces Second-Quarter 2022 Results Businesswire
03-Aug-2022 GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022 Businesswire
03-Aug-2022 Heather Knight Joins Channel Medsystems Board of Directors Businesswire
03-Aug-2022 ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP Businesswire
03-Aug-2022 Merck Provides Update on Phase 3 KEYNOTE-921 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer Businesswire